Ester Carballo‐Jane

1.6k total citations
22 papers, 481 citations indexed

About

Ester Carballo‐Jane is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Ester Carballo‐Jane has authored 22 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Surgery. Recurrent topics in Ester Carballo‐Jane's work include Receptor Mechanisms and Signaling (5 papers), Cholesterol and Lipid Metabolism (4 papers) and Melanoma and MAPK Pathways (3 papers). Ester Carballo‐Jane is often cited by papers focused on Receptor Mechanisms and Signaling (5 papers), Cholesterol and Lipid Metabolism (4 papers) and Melanoma and MAPK Pathways (3 papers). Ester Carballo‐Jane collaborates with scholars based in United States, France and Australia. Ester Carballo‐Jane's co-authors include Silvi Luell, Xinchun Tong, Andrew K.P. Taggart, M. Gerard Waters, Steven L. Colletti, James R. Tata, Kang Cheng, Ning Ren, Tian‐Quan Cai and Qiaolin Deng and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and American Journal of Physiology-Endocrinology and Metabolism.

In The Last Decade

Ester Carballo‐Jane

22 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ester Carballo‐Jane United States 14 239 136 48 46 46 22 481
Ja Young Koo South Korea 13 395 1.7× 152 1.1× 38 0.8× 29 0.6× 77 1.7× 25 684
John S. Major United Kingdom 13 282 1.2× 163 1.2× 39 0.8× 40 0.9× 26 0.6× 27 578
Maria V. Fawaz United States 12 231 1.0× 35 0.3× 60 1.3× 36 0.8× 111 2.4× 23 529
Antonio Limatola Italy 12 249 1.0× 92 0.7× 59 1.2× 36 0.8× 34 0.7× 16 475
Seung Hun Jeong South Korea 17 546 2.3× 75 0.6× 25 0.5× 35 0.8× 95 2.1× 33 854
Patrick Berna France 12 313 1.3× 88 0.6× 50 1.0× 12 0.3× 55 1.2× 18 505
Sharon Rossiter United Kingdom 12 244 1.0× 206 1.5× 43 0.9× 43 0.9× 273 5.9× 21 761
Roberta Ottria Italy 17 338 1.4× 66 0.5× 43 0.9× 30 0.7× 26 0.6× 45 695
Sang Dal Rhee South Korea 13 145 0.6× 240 1.8× 75 1.6× 136 3.0× 35 0.8× 26 566
Craig H. Miller United States 13 357 1.5× 141 1.0× 37 0.8× 27 0.6× 102 2.2× 17 717

Countries citing papers authored by Ester Carballo‐Jane

Since Specialization
Citations

This map shows the geographic impact of Ester Carballo‐Jane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ester Carballo‐Jane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ester Carballo‐Jane more than expected).

Fields of papers citing papers by Ester Carballo‐Jane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ester Carballo‐Jane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ester Carballo‐Jane. The network helps show where Ester Carballo‐Jane may publish in the future.

Co-authorship network of co-authors of Ester Carballo‐Jane

This figure shows the co-authorship network connecting the top 25 collaborators of Ester Carballo‐Jane. A scholar is included among the top collaborators of Ester Carballo‐Jane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ester Carballo‐Jane. Ester Carballo‐Jane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Heather, Thomas W. Rosahl, Ester Carballo‐Jane, et al.. (2025). Loss of mitochondrial amidoxime-reducing component 1 (mARC1) prevents disease progression by reducing fibrosis in multiple mouse models of chronic liver disease. Hepatology Communications. 9(2). 1 indexed citations
2.
Hentsch, Didier, Hugues Jacobs, Fabien Pertuy, et al.. (2021). High Resolution Episcopic Microscopy for Qualitative and Quantitative Data in Phenotyping Altered Embryos and Adult Mice Using the New “Histo3D” System. Biomedicines. 9(7). 767–767. 8 indexed citations
3.
Wang, Yichen, Ying Chen, Haihong Zhou, et al.. (2019). Spatial and temporal studies of metabolic activity: contrasting biochemical kinetics in tissues and pathways during fasted and fed states. American Journal of Physiology-Endocrinology and Metabolism. 316(6). E1105–E1117. 7 indexed citations
4.
He, Huaibing, Ester Carballo‐Jane, Xinchun Tong, & Lucinda H. Cohen. (2015). Measurement of catecholamines in rat and mini-pig plasma and urine by liquid chromatography–tandem mass spectrometry coupled with solid phase extraction. Journal of Chromatography B. 997. 154–161. 22 indexed citations
5.
Chen, Zhu, Edward A. O’Neill, Roger Meurer, et al.. (2011). Reconstituted HDL Elicits Marked Changes in Plasma Lipids Following Single-Dose Injection in C57Bl/6 Mice. Journal of Cardiovascular Pharmacology and Therapeutics. 17(3). 315–323. 19 indexed citations
6.
Schmidt, Darby, Subharekha Raghavan, Hong C. Shen, et al.. (2010). Anthranilic acid replacements in a niacin receptor agonist. Bioorganic & Medicinal Chemistry Letters. 20(11). 3426–3430. 17 indexed citations
7.
Boatman, P. Douglas, Thomas O. Schrader, Benjamin Johnson, et al.. (2010). Potent tricyclic pyrazole tetrazole agonists of the nicotinic acid receptor (GPR109a). Bioorganic & Medicinal Chemistry Letters. 20(9). 2797–2800. 23 indexed citations
8.
Blom, Daniël, Ting-Ting Yamin, Marie‐France Champy, et al.. (2010). Altered lipoprotein metabolism in P2Y13 knockout mice. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1801(12). 1349–1360. 38 indexed citations
9.
Imbriglio, Jason E., Rui Liang, Subharekha Raghavan, et al.. (2010). GPR109a agonists. Part 2: Pyrazole-acids as agonists of the human orphan G-protein coupled receptor GPR109a. Bioorganic & Medicinal Chemistry Letters. 20(15). 4472–4474. 10 indexed citations
10.
Schmidt, Darby, Subharekha Raghavan, Ester Carballo‐Jane, et al.. (2009). Pyrazole acids as niacin receptor agonists for the treatment of dyslipidemia. Bioorganic & Medicinal Chemistry Letters. 19(16). 4768–4772. 10 indexed citations
11.
Imbriglio, Jason E., Rui Liang, Subharekha Raghavan, et al.. (2009). GPR109a agonists. Part 1: 5-Alkyl and 5-aryl-pyrazole–tetrazoles as agonists of the human orphan G-protein coupled receptor GPR109a. Bioorganic & Medicinal Chemistry Letters. 19(8). 2121–2124. 13 indexed citations
12.
Lin, Songnian, Jeffrey J. Hale, Sander G. Mills, et al.. (2009). Novel 1-(2-aminopyrazin-3-yl)methyl-2-thioureas as potent inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2). Bioorganic & Medicinal Chemistry Letters. 19(12). 3238–3242. 18 indexed citations
13.
Deng, Qiaolin, Richard T. Beresis, Ning Ren, et al.. (2008). Molecular modeling aided design of nicotinic acid receptor GPR109A agonists. Bioorganic & Medicinal Chemistry Letters. 18(18). 4963–4967. 20 indexed citations
14.
Shen, Hong C., Michael J. Szymonifka, Qiaolin Deng, et al.. (2007). Discovery of orally bioavailable and novel urea agonists of the high affinity niacin receptor GPR109A. Bioorganic & Medicinal Chemistry Letters. 17(24). 6723–6728. 16 indexed citations
15.
Carballo‐Jane, Ester, Silvi Luell, Michael W. Wolff, et al.. (2007). Comparison of rat and dog models of vasodilatation and lipolysis for the calculation of a therapeutic index for GPR109A agonists. Journal of Pharmacological and Toxicological Methods. 56(3). 308–316. 13 indexed citations
16.
O’Keefe, Stephen J., John S. Mudgett, Janey N. Parsons, et al.. (2007). Chemical Genetics Define the Roles of p38α and p38β in Acute and Chronic Inflammation. Journal of Biological Chemistry. 282(48). 34663–34671. 70 indexed citations
17.
Carballo‐Jane, Ester, Silvi Luell, John Woods, et al.. (2007). Potential role for epidermal Langerhans cells in nicotinic acid-induced vasodilatation in the mouse. Inflammation Research. 56(6). 254–261. 6 indexed citations
18.
Natarajan, S., Luping Liu, James E. Thompson, et al.. (2006). p38 MAP kinase inhibitors. Part 5: Discovery of an orally bio-available and highly efficacious compound based on the 7-amino-naphthyridone scaffold. Bioorganic & Medicinal Chemistry Letters. 16(20). 5468–5471. 11 indexed citations
19.
McCallum, Christine, Penny Leavitt, Wesley L. Shoop, et al.. (2005). In vitroversusin vivoeffects of triptolide: the role of transcriptional inhibition. Therapy. 2(2). 261–273. 12 indexed citations
20.
Carballo‐Jane, Ester, Shilpa Pandit, Joseph C. Santoro, et al.. (2004). Skeletal muscle: a dual system to measure glucocorticoid-dependent transactivation and transrepression of gene regulation. The Journal of Steroid Biochemistry and Molecular Biology. 88(2). 191–201. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026